Oncology

Latest News

At 3 months, hospitalizations among patients enrolled in RSM were 19% lower vs historical controls. | Image Credit: Nuttapong punna - stock.adobe.com

Remote Symptom Monitoring Linked to Reduced Hospitalization Risk for Patients With Cancer

By Rose McNulty

May 14th 2025

Remote symptom monitoring in cancer care reduces hospitalizations, enhances value-based care, and supports diverse patient populations, according to new findings.

Offline data augmentation can significantly enhance deep learning techniques, improving classification performance compared to models trained solely on original clinician skin images. | Image Credit: Alexander - stock.adobe.com

Optimized Deep Learning Model Classifies Smartphone Images of Malignant Skin Lesions

By AJMC Contributor

May 12th 2025

With inconclusive treatment guidance and varying findings from clinical trials, the prognosis of transformed SCLC remains poor. | Image credit: Crystal Light - stock.adobe.com

Whole Exome Sequencing Identifies Distinct Profile of Transformed SCLC

By AJMC Contributor

May 12th 2025

The report suggests a TBS cutoff value of 3 will serve as a meaningful prognostic tool in HCC, but differences in patient populations and imaging techniques may affect the value of that cutoff, the authors noted. | Image credit: Jo Panuwat D - stock.adobe.com

HCC Tumor Burden Score Predicts Long-Term Outcomes Following MWA

By Jared Kaltwasser

May 7th 2025

Doctor showing lung x ray | Image credit: didesign – stock.adobe.com

Tarlatamab Safety Varies Between Clinical and Real-World SCLC Trials

By Hayden E. Klein

May 6th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Predicting AML Outcomes by Monitoring Minimal Residual Disease

February 2nd 2019

Predicting AML Outcomes by Monitoring Minimal Residual Disease

Laura Joszt, MA

Abstracts presented at the 60th American Society of Hematology Annual Meeting & Exposition looked at how monitoring minimal residual disease can help predict outcomes in acute myeloid leukemia (AML).

Review Identifies Potential Predictive Biomarkers in Colorectal Cancer

February 2nd 2019

Review Identifies Potential Predictive Biomarkers in Colorectal Cancer

David Bai, PharmD

A recent review outlined a vast array of biomarkers that may have clinical implications on the treatment and prognosis of colorectal cancer (CRC).

This Week in Managed Care: February 1, 2019

February 1st 2019

This Week in Managed Care: February 1, 2019

This week, the top managed care news included House and Senate hearings on the cost of prescription drugs; a study finding patients with diabetes can be safely switched to cheaper insulin; and the first non-chemotherapy combination being approved for the treatment of chronic lymphocytic leukemia.

AJMC® in the Press, February 1, 2019

February 1st 2019

AJMC® in the Press, February 1, 2019

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

ASCO Names "Progress in Treating Rare Cancers" as the Advance of the Year

January 31st 2019

ASCO Names "Progress in Treating Rare Cancers" as the Advance of the Year

Jaime Rosenberg

Reflecting on a year of breakthrough advancements in the treatment of rare, difficult to treat cancers, the American Society of Clinical Oncology (ASCO) has named “Progress in Treating Rare Cancers” as the Advance of the Year.

Discussing the Continuing Decline in Overall Cancer Mortality in the United States

January 30th 2019

Discussing the Continuing Decline in Overall Cancer Mortality in the United States

In this podcast, we speak with Rebecca Siegel, MPH, strategic director of surveillance information services in the Intramural Research Department at the American Cancer Society, and the lead author of the annual Cancer Statistics report that estimates the number of new cancer cases and deaths in the United States each year.

January 30th 2019

Mantle Cell Lymphoma (MCL): Treatment Landscape and Access to Care

https://www.pharmacytimes.org/on-demand/mantle-cell-lymphoma-mcl-treatment-landscape-and-access-to-care

Care Coordination Is the Top Investment Cancer Programs Can Make, Respondents Say

January 29th 2019

Care Coordination Is the Top Investment Cancer Programs Can Make, Respondents Say

Laura Joszt, MA

The ninth annual Trending Now in Cancer Care survey identified current and emerging trends for US cancer programs, such as the ongoing threat of drug costs and popular services progams are planning to add in the next 2 years.

FDA Approves Ibrutinib Combination as Frontline Treatment for CLL

January 29th 2019

FDA Approves Ibrutinib Combination as Frontline Treatment for CLL

Jaime Rosenberg

The approval marks the first non-chemotherapy combination regimen for the treatment of patients with chronic lymphocytic leukemia (CLL).

January 23rd 2019

Managed Care Considerations in Meeting the Complex Needs of Patients with Pancreatic Cancer

https://www.pharmacytimes.org/on-demand/managed-care-considerations-in-meeting-the-complex-needs-of-patients-with-pancreatic-cancer

Treatment Advances Make Supportive Care More Important in Multiple Myeloma

January 22nd 2019

Treatment Advances Make Supportive Care More Important in Multiple Myeloma

Laura Joszt, MA

As patients with multiple myeloma live longer thanks to advancements in treatments, more attention is being paid to treatment-related toxicities that are becoming more relevant.

Podcast: This Week in Managed Care—New Drug Pricing Probe and Other Health News

January 20th 2019

Podcast: This Week in Managed Care—New Drug Pricing Probe and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Dr Sibel Blau Discusses the Role of the Quality Cancer Care Alliance

January 20th 2019

Dr Sibel Blau Discusses the Role of the Quality Cancer Care Alliance

As the first clinically integrated oncology network, the Quality Cancer Care Alliance (QCCA) brings together the best practices and shares knowledge on value-based care, said Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.

Tumor Mutational Burden Predicts Who Will Respond to Immunotherapy

January 19th 2019

Tumor Mutational Burden Predicts Who Will Respond to Immunotherapy

Jaime Rosenberg

Higher tumor mutational burden is associated with improved overall survival in patients with stage IV or metastatic disease being treated with immune checkpoint inhibitors.

Once-Weekly Carfilzomib Improves PFS, OS in High-Risk Patients With MM Over Twice-Weekly Dose

January 19th 2019

Once-Weekly Carfilzomib Improves PFS, OS in High-Risk Patients With MM Over Twice-Weekly Dose

Laura Joszt, MA

Patients with multiple myeloma (MM) who have high-risk cytogenetic abnormalities typically have shorter progression-free survival (PFS) and overall survival (OS) compared with standard-risk patients. In an analysis of 2 studies, patients with high-risk MM had improved outcomes when taking carfilzomib once a week compared with a twice-weekly dose.

January 19th 2019

AJMCtv® Interviews, January 2019

Samantha DiGrande Jaime Rosenberg

AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.

January 19th 2019

Updates from the annual ASH meeting, December 2018.

This Week in Managed Care: January 18, 2019

January 18th 2019

This Week in Managed Care: January 18, 2019

This week, the top managed care news included a new investigation into drug prices; FDA Commissioner Scott Gottlieb, MD, provided updates on how the government shutdown is impacting FDA work; research found comorbidities impede clinical trial participation for patients with cancer.

January 18th 2019

Quality of Life

Updates from the annual ASH meeting, December 2018.

USPSTF Releases Draft Recommendation on Drugs to Lower Risk of Breast Cancer

January 18th 2019

USPSTF Releases Draft Recommendation on Drugs to Lower Risk of Breast Cancer

Samantha DiGrande

Earlier this week, the US Preventive Services Task Force (USPSTF) released a draft guidance recommendations on medications for women at an increased risk for breast cancer.

January 18th 2019

Cost of Care: Biosimilars

Updates from the annual ASH meeting, December 2018.

January 18th 2019

Updates from the annual ASH meeting, December 2018.

January 17th 2019

Clinical: Lymphoma

Updates from the annual ASH meeting, December 2018.

January 17th 2019

Clinical: Myelofibrosis

Updates from annual ASH meeting, December 2018.

January 17th 2019

Clinical: Chronic Lymphocytic Leukemia

Updates from the annual ASH meeting, December 2018.

January 17th 2019

Clinical: Multiple Myeloma

Updates from the annual ASH meeting, December 2018.

January 17th 2019

Clinical: CAR T-Cell Therapy

Updates from the Annual ASH meeting, December 2018.

African American Women Are at a Disadvantage in Preventing Breast Cancer

January 16th 2019

African American Women Are at a Disadvantage in Preventing Breast Cancer

Breast cancer risk estimation models identify women who are at high risk based on a variety of factors, and women who are identified as being at high risk may be able to reduce their chance of breast cancer through preventative measures such as prophylactic surgeries or chemoprevention medications. However, uptake of these preventative treatments varies among racial groups, new research from The Ohio State University finds that racial disparities in healthcare are to blame.

Comorbidities Impede Clinical Trial Participation Among Patients With Cancer

January 16th 2019

Comorbidities Impede Clinical Trial Participation Among Patients With Cancer

Jaime Rosenberg

Patients with cancer who have comorbidities are less likely to have clinical trial discussions, be offered a clinical trial, and participate in a clinical trial, according to a new study.

Podcast: This Week in Managed Care—Coverage From the JP Morgan Healthcare Conference and Other Health News

January 13th 2019

Podcast: This Week in Managed Care—Coverage From the JP Morgan Healthcare Conference and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

...

30 31 32 33 34 35 36 37 38

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions